How could we have better vaccines against tuberculosis? - Wikidata - wikimedia - TriplyDB

How could we have better vaccines against tuberculosis?

How could we have better vaccines against tuberculosis?

http://www.wikidata.org/entity/Q57112024

about

A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells

P2860

Q33459148-CA8548CF-DC7B-4139-80E6-EF7C28D1D739

P2860

How could we have better vaccines against tuberculosis?

http://www.wikidata.org/entity/Q57112024

description

im November 2008 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2008

@uk

name

How could we have better vaccines against tuberculosis?

@en

How could we have better vaccines against tuberculosis?

@nl

type

label

How could we have better vaccines against tuberculosis?

@en

How could we have better vaccines against tuberculosis?

@nl

prefLabel

How could we have better vaccines against tuberculosis?

@en

How could we have better vaccines against tuberculosis?

@nl

P1433

Q57112024-BAFCA99A-499E-46EE-A3CA-3636B194DD33

P1476

Q57112024-BFB5E482-2B6B-407C-9AAC-D5589B700DA8

P2093

Q57112024-5519B3AF-F224-4D23-9DE8-E453DBBFEE1E

P2860

Q57112024-01F6521C-908C-416B-ACB7-E0F0B9E4F081

Q57112024-0527767E-165C-4838-A901-830B9744B908

Q57112024-073D314F-2EEA-4503-B0D2-8C819422D933

Q57112024-09886747-07F0-47C2-BDB5-DF7AAD8292A8

Q57112024-0B75616F-1E67-486E-AB7D-8FCE4EE31FAD

Q57112024-0ECE59E2-8D2F-450D-B774-06091DD9CCED

Q57112024-0F39DB14-9979-46DD-B08B-7B8887BFF88C

Q57112024-129D2D0C-34FC-4F42-9B46-D271C1D63391

Q57112024-12A530F2-ED51-43FF-B036-CB0FA41DFF49

Q57112024-15208151-136B-468E-BEBE-F61378F73570

P304

Q57112024-19808FE0-717E-4D8F-A3C1-5AB29DC2469B

P31

Q57112024-54fc17f0-0277-43ef-b931-5facb8e7c4ba

Q57112024-CD46E80C-D552-4CD5-A16E-0A716AFF177D

P356

Q57112024-26281D5F-842E-4962-895D-D441E32EE72F

P407

Q57112024-6B0DDE06-01DC-4831-B7EA-73F7FF682DD0

P433

Q57112024-1C499A5A-4436-454C-869C-4817525EFC31

P478

Q57112024-2DB20AB2-E84C-4059-AF4D-5110C373B50B

P577

Q57112024-8ADBD1C9-6173-4E0D-9B69-ED5CE3CA3635

P698

Q57112024-EA52FD99-B2BF-4296-9710-2D17BD02BB90

P921

Q57112024-EA1096AF-0531-4FB5-B635-8399381AE9AF

P356

14712598.8.11.1759

P1433

Expert Opinion on Biological Therapy

P1476

How could we have better vaccines against tuberculosis?

@en

P2093

Pramod K Giri

http://www.w3.org/2001/XMLSchema#string

P2860

An antimicrobial activity of cytolytic T cells mediated by granulysin

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa

Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model

CD1: antigen presentation and T cell function

A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage

Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guérin (BCG) vaccination

Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase

Comparative genomics of BCG vaccines by whole-genome DNA microarray

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

T-cell antigen receptor genes and T-cell recognition

P304

1759-72

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.8.11.1759

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2008-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18847310

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde